chr5-205907-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145265.3(CCDC127):c.173C>A(p.Ala58Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC127 | NM_145265.3 | c.173C>A | p.Ala58Asp | missense_variant | 3/3 | ENST00000296824.4 | NP_660308.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC127 | ENST00000296824.4 | c.173C>A | p.Ala58Asp | missense_variant | 3/3 | 1 | NM_145265.3 | ENSP00000296824 | P1 | |
CCDC127 | ENST00000441693.2 | c.173C>A | p.Ala58Asp | missense_variant | 2/2 | 2 | ENSP00000411206 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251400Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135878
GnomAD4 exome AF: 0.000148 AC: 217AN: 1461736Hom.: 0 Cov.: 31 AF XY: 0.000140 AC XY: 102AN XY: 727162
GnomAD4 genome AF: 0.000105 AC: 16AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.173C>A (p.A58D) alteration is located in exon 3 (coding exon 2) of the CCDC127 gene. This alteration results from a C to A substitution at nucleotide position 173, causing the alanine (A) at amino acid position 58 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at